Patents by Inventor Scott L. Schissel

Scott L. Schissel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040047851
    Abstract: The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject.
    Type: Application
    Filed: August 22, 2003
    Publication date: March 11, 2004
    Applicant: The Trustees of Columbia University
    Inventors: Ira Tabas, Scott L. Schissel, Kevin Jon Williams
  • Patent number: 6613322
    Abstract: The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: September 2, 2003
    Assignees: The Trustees of Columbia University in the City of New York, Thomas Jefferson University
    Inventors: Ira Tabas, Scott L. Schissel, Kevin Jon Williams
  • Publication number: 20030026796
    Abstract: The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject.
    Type: Application
    Filed: March 3, 2000
    Publication date: February 6, 2003
    Inventors: Ira Tabas, Scott L. Schissel, Kevin Jon Williams
  • Patent number: 5989803
    Abstract: The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingmyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: November 23, 1999
    Assignees: The Trustees of Columbia University in the City of New York, Thomas Jefferson University
    Inventors: Ira Tabas, Scott L. Schissel, Kevin Jon Williams